A
Alterola Biotech, Inc. (ABTI)
PNK – Real Time Price. Currency in USD
0.00
0.00 (0.00%)
Market open: Sep 8, 2026, 4:00 PM EDT
Find any stock by ticker or company name

PNK – Real Time Price. Currency in USD
0.00
0.00 (0.00%)
Market open: Sep 8, 2026, 4:00 PM EDT
Alterola Biotech, Inc., a pharmaceutical company, engages in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules. It focuses on the development of regulated human and animal health pharmaceuticals and regulated food products; production of active pharmaceutical ingredients and food-grade ingredients; and formulation and drug delivery for improved bioavailability, solubility, and stability. Alterola Biotech, Inc. is based in Birkenhead, the United Kingdom.
| Name | Position |
|---|---|
| Mr. Colin G. Stott B.Sc. | COO & Director |
| Mr. David John Hitchcock O.B.E. | Chief Executive Officer |
| Mr. Dominic Schiller | IP Counsel, Chief IP Officer & Director |
| Mr. Nathan Thompson | CFO & Secretary |
| Date | Type | Document |
|---|---|---|
| 2025-06-30 | 8-K | abti_8k.htm |
| 2024-11-29 | 10-Q | abti_10q.htm |
| 2024-11-25 | 10-Q/A | abti_10qa.htm |
| 2024-11-14 | NT 10-Q | abti_nt10q.htm |
| 2024-09-30 | 8-K | abti8k092724.htm |
| 2024-09-12 | 8-K | abti8k091224.htm |
| 2024-08-15 | 10-Q | abti10q1_063024.htm |
| 2024-08-14 | NT 10-Q | abti_nt10q.htm |
| 2024-07-18 | 10-K | abti10k_033124.htm |
| 2024-06-28 | NT 10-K | abti_nt10k.htm |